港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

抗疫概念

883.647

+5.1590.59%

漲家數：7

跌家數：8

平家數：2

市盈率：- -

高：884.571

開：878.433

低：868.104

收：878.487

成交量：1.15億

成交額：8.52億

市值：5,969.20億

流通市值：4,945.61億

資料載入中...

總覽新聞資訊

中國生物製藥(01177.HK)：TQC3721吸入粉霧劑(PDE3/4抑制劑)於ERS 2026公布I期臨床研究數據

曾被估價1.54億元,如今2400萬元掛牌濟南平嘉大藥房60%股權再尋買家

復星醫藥(02196)9月7日斥資117.52萬港元回購7萬股

貝萊德在國藥控股的H股好倉比例下降0.15%至8.92%

南方财经网

破發股君實生物跌2.15% 2020年上市2募資共86億元

港股異動 | 比亞迪電子(00285.HK)升逾7% 主要客户旺季來臨疊加液冷產能逐步提升大摩看好後續業績改善

阿里健康(00241)出現大手買入130萬股，成交價$3.15，涉資409.5萬

阿斯达克财经

復星醫藥控股股東質押3.3億股還債累計質押比例超7成

教育部：把教師不必要的檢查、評比、填表真正減下來

港股異動 | 歌禮制藥-B(01672.HK)午後升逾6% 公司正式進入港股通名單 ASC30近期完成首例入組

同源康醫藥－Ｂ(02410)股價大幅下跌26.833%，現價港幣$4.54

阿斯达克财经

比亞迪電子(00285)出現大手賣出73萬股，成交價$25.66，涉資1.873千萬

阿斯达克财经

歌禮制藥納入港股通今日正式生效

歌禮制藥-B獲納入滬深港通下港股通名單

歌禮制藥-B(01672.HK)獲納入滬港通及深港通計劃項下的港股通名單

歌禮制藥－Ｂ(01672)股價下跌8.474%，現價港幣$9.235

阿斯达克财经

復星國際(00656.HK)：復星醫藥(02196.HK)減持印度注射劑藥品生產製造公司6%股權套現2.94億美元

阿斯达克财经

深交所：將歌禮制藥(01672)、曦智科技(01879)等調入深港通下的港股通標的

中國中藥(00570.HK)醒脾解鬱片獲批上市

阿斯达克财经

瑞銀：中國生物科技企業上半年銷售大多勝預期下半年全球研發催化劑成關鍵首選百濟神州(ONC.US)

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/BK1515/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"抗疫概念","latestPrice":883.6466,"timestamp":1789617598991,"preClose":878.48724,"halted":0,"volume":115090686,"delay":0,"changeRate":0.005873,"floatShares":0,"shares":0,"eps":0,"marketStatus":"午間休市","change":5.159363,"latestTime":"09-17 12:00:00","open":878.4325,"high":884.57117,"low":868.10425,"amount":852383942,"amplitude":0.018745,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789621200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":1.317311,"peRate":17.071131,"turnoverRate":0.001577,"increases":7,"decrements":8,"flats":2,"marketCap":596920193728,"floatMarketCap":494560648832},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":884.57117,"amplitude":0.018745,"preClose":878.48724,"low":868.10425,"pbRate":"1.317311","latestPrice":883.6466,"volume":115090686,"delay":0,"open":878.4325,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":890.408,"twentyDayClose":941.274,"sixtyDayClose":813.549,"secType":"PLATE","market":"HK","turnoverRate":0.001577,"peRate":17.071131,"marketCap":596920193728,"floatMarketCap":494560648832,"timestamp":1789617598991,"nameCN":"抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":7,"down":8,"flat":2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665131659","title":"中國生物製藥(01177.HK)：TQC3721吸入粉霧劑(PDE3/4抑制劑)於ERS 2026公布I期臨床研究數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2665131659","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665131659?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:39","pubTimestamp":1788777571,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1191","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","HK0000165453.HKD","BK1589","IE00BZ08YR35.GBP","BK1521","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665319588","title":"曾被估價1.54億元,如今2400萬元掛牌 濟南平嘉大藥房60%股權再尋買家","url":"https://stock-news.laohu8.com/highlight/detail?id=2665319588","media":"经济导报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665319588?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:08","pubTimestamp":1788775680,"startTime":"0","endTime":"0","summary":"目前,济南平嘉股东分别为天士力医药和董红兵,持股比例分别为60%和40%。此次挂牌转让的,正是天士力医药所持有的60%股权。此次挂牌之所以引发关注,一个重要原因在于济南平嘉60%股权此前曾以较高价格进入市场视野。当时的评估结果显示,以2023年3月31日为评估基准日,济南平嘉100%股权评估值为26071.26万元,评估增值率达到1099.54%。如今,两年多时间过去,济南平嘉60%股权再次被摆上产权交易市场,挂牌底价已经变为2400万元。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-07/doc-iniqyzxs9592354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1515","301017","BK0209","09939","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665315565","title":"復星醫藥(02196)9月7日斥資117.52萬港元回購7萬股","url":"https://stock-news.laohu8.com/highlight/detail?id=2665315565","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665315565?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 18:00","pubTimestamp":1788775238,"startTime":"0","endTime":"0","summary":"智通财经APP讯，复星医药(02196)发布公告，于2026年9月7日，该公司斥资117.52万港元回购7万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492862.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","BK1593","600196","BK0012","BK0196","BK1515","BK0060","BK0183","BK0096","BK0175","02196","BK0028","BK0239","BK1191","BK0187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665313965","title":"貝萊德在國藥控股的H股好倉比例下降0.15%至8.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665313965","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665313965?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 17:20","pubTimestamp":1788772800,"startTime":"0","endTime":"0","summary":"南财智讯9月7日电，香港交易所披露信息显示，BlackRock,Inc.（贝莱德）在国药控股的H股好仓（L）比例于9月2日从9.07%下降至8.92%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866754446.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866754446.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1515","BK1197","01099","LU0640798160.USD","BK1500","LU1115378108.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665188703","title":"破發股君實生物跌2.15% 2020年上市2募資共86億元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665188703","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665188703?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 16:33","pubTimestamp":1788769993,"startTime":"0","endTime":"0","summary":"中国经济网北京9月7日讯 君实生物 今日收报32.77元，跌幅2.15%。该股目前处于破发状态。　　上市首日，君实生物股价最高报220.40元，为上市以来股价最高点。　　君实生物首次公开发行股票募集资金总额为48.36亿元，扣除发行费用后，募集资金净额为44.97亿元，较原计划多17.97亿元。　　君实生物首次公开发行股票发行费用为3.39亿元，其中，保荐及承销费用3.20亿元。　　经计算，君实生物两次募集资金合计86.12亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260907/32362114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01877","BK1161","IPOS","BK1515","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665339795","title":"港股異動 | 比亞迪電子(00285.HK)升逾7% 主要客户旺季來臨疊加液冷產能逐步提升 大摩看好後續業績改善","url":"https://stock-news.laohu8.com/highlight/detail?id=2665339795","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665339795?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 15:32","pubTimestamp":1788766347,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1580","BK1589","BK1515","00285","LU0274383008.USD","LU0348766576.USD","BK1540","BK1582","BK1149","BK1167","BK1504","LU0348767384.USD","BK1607"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392139","title":"阿里健康(00241)出現大手買入130萬股，成交價$3.15，涉資409.5萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392139","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392139?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:54","pubTimestamp":1788764040,"startTime":"0","endTime":"0","summary":"[大手成交]阿里健康(00241)在下午02:54出现大手买入，成交量为130万，成交价为港币$3.15，涉资409.5万。至目前为止，股价升0.159%，今日最高价为$3.16，而最低价为$3.115，总成交量为1.884千万股，总成交金额港币$5.909千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145554547_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609076083/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2609076083/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1189","BK1571","BK1502","BK1247","BK1615","HK0000165453.HKD","BK1515","BK1584","BK1589","00241","BK1617","BK1610","BK1142","BK1591","BK1501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665392895","title":"復星醫藥控股股東質押3.3億股還債 累計質押比例超7成","url":"https://stock-news.laohu8.com/highlight/detail?id=2665392895","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665392895?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:37","pubTimestamp":1788763023,"startTime":"0","endTime":"0","summary":"中国经济网北京9月7日讯 复星医药 9月5日披露的关于股东部分股份质押的公告显示，公司于2026年9月4日接到控股股东上海复星高科技(集团)有限公司的通知，其已将所持有的公司部分A股股份办理质押手续。　　复星高科技本次质押股份数量为3.3亿股，占其所持股份数比例的34.32%，占公司股份总数比例为12.36%。质押起始日为2026年9月3日，质押到期日为2028年9月8日。　　控股股东复星高科技质押公司股份均系用于融资。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/07/20260907896860.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/07/20260907896860.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260907/32361887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0187","BK1515","BK0239","BK0175","BK0028","BK0096","BK0188","02196","BK0196","BK0060","600196","BK1191","BK1593","BK0012","BK0183"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665539490","title":"教育部：把教師不必要的檢查、評比、填表真正減下來","url":"https://stock-news.laohu8.com/highlight/detail?id=2665539490","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665539490?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:27","pubTimestamp":1788762449,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK1502","BK1617","BK1142","BK1610","00241","BK1589","BK1584","BK1591","HK0000165453.HKD","BK1571","BK1615","BK1515","BK1189","BK1247","BK1501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394527","title":"港股異動 | 歌禮制藥-B(01672.HK)午後升逾6% 公司正式進入港股通名單  ASC30近期完成首例入組","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394527","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394527?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:15","pubTimestamp":1788761745,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1515","BK1574","BK1191","BK1161","01672","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665394677","title":"同源康醫藥－Ｂ(02410)股價大幅下跌26.833%，現價港幣$4.54","url":"https://stock-news.laohu8.com/highlight/detail?id=2665394677","media":"阿斯达克财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665394677?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 14:04","pubTimestamp":1788761040,"startTime":"0","endTime":"0","summary":"[下跌股]同源康医药－Ｂ(02410) 股价在下午02:04比前收市价大幅下跌26.833%，现股价为港币$4.54。至目前为止，今日最高价为$5.905，而最低价为$4.54。总成交量为538.3万股，总成交金额为港币$2.673千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180416150425748_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609072429/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609072429/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","BK1515","09939","BK1161","02410","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665697391","title":"比亞迪電子(00285)出現大手賣出73萬股，成交價$25.66，涉資1.873千萬","url":"https://stock-news.laohu8.com/highlight/detail?id=2665697391","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665697391?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 13:25","pubTimestamp":1788758700,"startTime":"0","endTime":"0","summary":"[大手成交]比亚迪电子(00285)在下午01:25出现大手卖出，成交量为73万，成交价为港币$25.66，涉资1.873千万。至目前为止，股价升2.385%，今日最高价为$25.92，而最低价为$25.06，总成交量为659.13万股，总成交金额港币$1.687亿。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145555799_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609074959/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2609074959/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["00285","BK1167","BK1540","BK1515","BK1504","BK1149","LU0348767384.USD","BK1580","BK1607","LU0348766576.USD","BK1582","BK1589","LU0274383008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399941","title":"歌禮制藥納入港股通 今日正式生效","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399941","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399941?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:25","pubTimestamp":1788755100,"startTime":"0","endTime":"0","summary":"歌礼制药（01672）发布公告，公司于2026年9月7日起，获纳入沪港通及深港通计划下的港股通名单。此次纳入将使符合相关资格的国内投资者能够通过港股通渠道交易公司股票。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609073866532228.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609073866532228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01477","BK1191","BK1515","FLHK","01672","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164090375","title":"歌禮制藥-B獲納入滬深港通下港股通名單","url":"https://stock-news.laohu8.com/highlight/detail?id=1164090375","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164090375?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:18","pubTimestamp":1788754680,"startTime":"0","endTime":"0","summary":"歌礼制药-B（Ascletis-B）宣布，公司已成功入选港股通名单，该名单适用于上海-香港股票市场交易互联互通机制以及深圳-香港股票市场交易互联互通机制。这一里程碑式的进展，标志着公司股票正式进入沪深港通体系，为两地投资者提供了更为便捷的投资通道。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1161","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665352399","title":"歌禮制藥-B(01672.HK)獲納入滬港通及深港通計劃項下的港股通名單","url":"https://stock-news.laohu8.com/highlight/detail?id=2665352399","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665352399?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 12:16","pubTimestamp":1788754601,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1515","BK1191","01477","BK1161","01672","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665954633","title":"歌禮制藥－Ｂ(01672)股價下跌8.474%，現價港幣$9.235","url":"https://stock-news.laohu8.com/highlight/detail?id=2665954633","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665954633?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:35","pubTimestamp":1788748500,"startTime":"0","endTime":"0","summary":"[下跌股]歌礼制药－Ｂ(01672) 股价在上午10:35比前收市价下跌8.474%，现股价为港币$9.235。至目前为止，今日最高价为$10.57，而最低价为$9.235。总成交量为287.599万股，总成交金额为港币$2.858千万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131622959_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609071531/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2609071531/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["01672","BK1161","BK1515","BK1574","BK1191","01477"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665839583","title":"復星國際(00656.HK)：復星醫藥(02196.HK)減持印度注射劑藥品生產製造公司6%股權  套現2.94億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2665839583","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665839583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 10:03","pubTimestamp":1788746580,"startTime":"0","endTime":"0","summary":"复星国际公布，附属复星医药全资附属复星医药新加坡公司，通过大宗交易及集中竞价方式出售共计989.7万股Gland Pharma Limited股份，约占该公司股份总数的6%，出售事项的总代价约为279.96亿卢比。Gland Pharma Limited是一间根据印度法律成立的公司，其主要从事注射剂药品的生产制造业务，其股份于孟买证券交易所及印度国家证券交易所上市，股份代号：GLAND。于出售事项前及完成后，复星国际分别持有Gland Pharma约51.76%及45.76%的股权，该公司仍为复星医药及复星国际的附属。","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220902164047308_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220902164047308_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543112/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543112/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0028","02196","BK0060","BK0183","BK0188","BK1191","600196","BK1230","BK1593","BK0187","BK0196","BK0096","BK0012","BK1515","BK0239","BK0175","MNDmain","00656"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665930583","title":"深交所：將歌禮制藥(01672)、曦智科技(01879)等調入深港通下的港股通標的","url":"https://stock-news.laohu8.com/highlight/detail?id=2665930583","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665930583?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:57","pubTimestamp":1788746223,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，9月7日，深交所公告，根据《深圳证券交易所深港通业务实施办法》的有关规定，港股通标的证券名单发生调整并自2026年09月07日起生效。调入歌礼制药(01672)、曦智科技(01879)、百度集团(09888)等，调出日清食品(01475)、海昌海洋公园(02255)、狮腾控股(02562)等。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260907/32361455.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01672","BK1161","01879","BK1163","FLHK","BK1191","BK1515","01477","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665937733","title":"中國中藥(00570.HK)醒脾解鬱片獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2665937733","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665937733?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:57","pubTimestamp":1788746220,"startTime":"0","endTime":"0","summary":"中国中药(00570.HK) 公布，经国家药监局完成技术审评、现场核查、抽样检验等一系列工作程序，同济堂制药申报的1.1类中药创新药醒脾解郁片已获得批准上市，药品上市许可持有人为同济堂制药。(ha/a)(港股报价延迟最少十五分钟。沽空资料截至 2026-09-04 16:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240130110317502_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240130110317502_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543108/latest-news/AAFN","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1543108/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1515","00570","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665931133","title":"瑞銀：中國生物科技企業上半年銷售大多勝預期 下半年全球研發催化劑成關鍵 首選百濟神州(ONC.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2665931133","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665931133?lang=zh_tw&edition=fundamental","pubTime":"2026-09-07 09:41","pubTimestamp":1788745283,"startTime":"0","endTime":"0","summary":"瑞银指出，上述11家公司今年上半年产品销售总额同比增长34%。百济神州上调指引，信达生物提供新的乐观指引，其余公司均维持全年指引，有信心达成或超额完成。报告提到，中国生物科技对外授权交易仍然活跃，截至8月底，今年以来首付款及总交易规模已分别达到2025年全年水平的90%及82%。瑞银预计，今年下半年学术会议季将于9月展开，重点关注WCLC/ESMO实体肿瘤会议及ASH血液学会议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1492581.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","09926","IE00B5MMRT66.SGD","06160","01801","LU1770034418.SGD","LU0561508036.HKD","LU2328871848.SGD","BK1583","LU0244354667.USD","ONC","KURE","BK0239","BK4588","LU1720050803.USD","LU0417516738.SGD","LU1303224171.USD","LU0348784397.USD","LU0348783233.USD","09969","LU0348767384.USD","LU1188198961.HKD","LU2242644610.SGD","LU2097828557.USD","LU1961090484.USD","LU0307460666.USD","LU0417516902.SGD","688235","BK1588","LU2778985437.USD","LU2097828631.EUR","LU2097828474.EUR","01877","03069","BK1515","LU0455707207.USD","IE00B543WZ88.USD","LU1719994722.HKD","LU0348825331.USD","LU1969619763.USD","LU0634319403.HKD","LU2399975544.HKD","BK4139","BK1161","HK0000165453.HKD","00013","LU0348735423.USD","LU0463099449.HKD","LU2476274308.USD","LU2476274720.SGD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}